Related Experiment Video
Updated: Jun 19, 2026
04:14
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
Published on: April 16, 2019
Endocannabinoids and non-alcoholic steatohepatitis
1Department of Liver Transplantation, Hepatobiliary & Pancreatic Surgery, King Faisal Specialist Hospital & Research Center (KFSH&RC), Riyadh, Saudi Arabia. ahsalem10@hotmail.com
Summary
Non-alcoholic steatohepatitis (NASH) may be treatable by targeting the endocannabinoid system (ECBs). CB1 receptor deficiency prevents fatty liver development in mice, suggesting ECBs as a therapeutic target for NASH.
Area of Science:
- Hepatology
- Endocrinology
- Pharmacology
Background:
- Non-alcoholic steatohepatitis (NASH) is increasingly prevalent, linked to metabolic disorders like diabetes and obesity.
- Endocannabinoids (ECBs) are endogenous compounds interacting with cannabinoid receptors (CB1 and CB2).
- CB1 and CB2 receptors are G-protein coupled and influence cellular signaling pathways.
Purpose of the Study:
- To explore the potential link between NASH and the endocannabinoid system.
- To review the role of ECBs in hepatic lipogenesis and their relevance to NASH pathogenesis.
Main Methods:
- Review of existing scientific literature on endocannabinoids, cannabinoid receptors, and non-alcoholic steatohepatitis.
- Analysis of studies investigating the effects of CB1 receptor deficiency on diet-induced hepatic steatosis in mice.
Main Results:
- CB1-deficient mice exhibited resistance to diet-induced hepatic steatosis.
- Wild-type mice developed significant hepatic steatosis after high-fat diet exposure.
- Endocannabinoid system modulation is implicated in regulating peripheral lipogenesis.
Conclusions:
- The hepatic endocannabinoid system presents a potential therapeutic target for managing NASH.
- CB1 receptor antagonists, like Rimonabant, may offer a non-surgical approach to obesity and potentially NASH treatment.
Related Concept Videos
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...